News & Media

Winnipeg innovator tackles Manitoba Diagnostic Backlog by bringing sleep lab to the home

Home grown technology supporting pandemic recovery

January 17, 2023: Winnipeg, Manitoba.

Cerebra, a Winnipeg based medical technology company advancing sleep disorder diagnostics, has entered into a contract with The Government of Manitoba under a Request for Supply Arrangement (RFSA) for the Provision of Diagnostic Services. Through the arrangement, Cerebra will work closely with the Province of Manitoba to reduce the backlog of diagnostic sleep studies caused by the Covid- 19 pandemic. The contract is for one thousand in-home polysomnography (PSG) studies and will begin early 2023. Referred patients will be able to perform a complete PSG in the comfort of their home providing comprehensive information comparable to that collected in a sleep lab.

“Bringing the sleep lab to the home has many benefits”, says Patrick Crampton, President and Chief Operating Officer at Cerebra. “Combining the convenience of traditional in-home sleep apnea studies with the much more comprehensive sleep analysis of a PSG is a major step forward in expanding diagnostic capabilities for both patients and sleep specialists.”

“Sleep is such a vital component for overall health. Undiagnosed sleep disorders can increase an individual’s risk of diabetes, obesity, hypertension and heart disease. The pandemic has impacted sleep study wait lists much the same as other areas of our healthcare system. The opportunity to leverage locally developed technology to help Manitobans is a great example of the innovation ecosystem Manitoba is developing. We are honored and excited to begin helping Manitobans and these one thousand studies are a great start.”


About Cerebra

Cerebra Medical Ltd. is a Canadian technology company transforming the future of sleep diagnosis and therapy. Cerebra unites innovators and researchers with the common goal and passion of putting “sleep” back into sleep medicine.

Cerebra Sleep System uses the patented algorithm, Odds Ratio Product (ORP) that micro analyses the Electroencephalogram (EEG) signal providing a continuous measure of sleep depth, moving beyond conventional scoring methods to dig deeper into brain activity. As a leader in sleep diagnostic technology, our innovative Cerebra Sleep System provides sleep researchers and clinicians with accurate, self-applied, in-home diagnostics.


For further information/media enquiries please contact:

Karli Struss

Marketing and Communications Manager, Cerebra 



News source: Cerebra